Canada markets closed

WPD Pharmaceuticals Inc. (WBIO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.04500.0000 (0.00%)
At close: 09:49AM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 5.10M
Enterprise Value 4.77M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)117.46
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.42

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 30.00%
S&P500 52-Week Change 322.36%
52 Week High 30.0450
52 Week Low 30.0450
50-Day Moving Average 30.0450
200-Day Moving Average 30.0450

Share Statistics

Avg Vol (3 month) 3N/A
Avg Vol (10 day) 3N/A
Shares Outstanding 5113.44M
Implied Shares Outstanding 6113.44M
Float 8N/A
% Held by Insiders 139.62%
% Held by Institutions 10.00%
Shares Short (May 31, 2022) 4191
Short Ratio (May 31, 2022) 40.15
Short % of Float (May 31, 2022) 4N/A
Short % of Shares Outstanding (May 31, 2022) 40.00%
Shares Short (prior month Apr 29, 2022) 425.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jul 17, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2022
Most Recent Quarter (mrq)Sept 30, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -230.98k
Net Income Avi to Common (ttm)5.97M
Diluted EPS (ttm)-0.6100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.46k
Total Cash Per Share (mrq)0
Total Debt (mrq)283.26k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.36
Book Value Per Share (mrq)-0.01

Cash Flow Statement

Operating Cash Flow (ttm)-889.79k
Levered Free Cash Flow (ttm)N/A